<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230901059319N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-10-05</date_registration>
      <primary_sponsor>Khatam University</primary_sponsor>
      <public_title>Investigating the effectiveness of integrated psychotherapy on generalized anxiety disorder</public_title>
      <acronym></acronym>
      <scientific_title>A Combined Protocol of Emotional Schema Therapy and Integrated Transdiagnostic Therapy on Brain Executive Functions and Emotional Regulation in People with Generalized Anxiety Disorder</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>5</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72378</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Generalized anxiety disorder.</hc_freetext>
      <i_freetext>"Intervention group: 5 participants in the research study, diagnosed with generalized anxiety disorder, participate in 10 individual psychotherapy sessions.The duration of each session is one hour. During the sessions Using the integrated protocol of Leahy's emotional schema therapy and Barlow's integrative transdiagnostic therapy , the evaluation and modification of emotional schemas, cognitive reconstruction, training and application of mindfulness, emotional regulation, and cognitive flexibility are addressed. Description of the intervention : Pre- Assessment The first stage involves a comprehensive assessment to evaluate the patient's level of anxiety, emotional regulation abilities, and executive function performance. Standardized assessment tools like the Generalized Anxiety Disorder 7-item (GAD-7) scale, Cognitive Regulation of Emotion Questionnaire (Garnefski and Kraaij, 2006), and Persian version of Adult Executive Functions Scale (Parhun et al., 2023) will be used. Schema Identification : We begin by identifying the patient's schemas that relate to their anxiety, focusing on the cognitive, emotional, and behavioral responses that contribute to their Generalized anxiety disorder. Schema Modification : Through a process of cognitive restructuring, patients are guided to challenge their schemas, change their maladaptive thought patterns, and develop healthier ways of interpreting their experiences.Emotional Regulation Training : We utilize the techniques from Dialectical Behavior Therapy (DBT) and Acceptance and Commitment Therapy (ACT) to teach patients skills to understand and manage their emotions better. Cognitive Flexibility Training : Using a combination of cognitive-behavioral techniques and mindfulness practices, we aim to enhance the patient's ability to shift their attention and adapt their thinking in response to changing circumstances.  Schema- Focused Emotional Regulation : After separately working on Emotional Schema Therapy and Integrated Transdiagnostic Therapy  , we integrate the two by focusing on schema-focused emotional regulation. This helps patients recognize and alter schemas while simultaneously regulating their emotions. Cognitive Flexibility and Schema Modification:  As patients gain better control over their emotional responses, we further integrate cognitive flexibility training within schema modification, which aids them to challenge and change their schemas more effectively.Post- Assessment : The same standardized tools used in the pre-assessment will be employed to evaluate the progress and efficacy of the therapy. Finally, patients are provided with strategies and plans to maintain their gains and cope with potential future stressors. Regular follow-ups are conducted to reinforce the therapy's effectiveness and manage any recurring symptoms.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is "Since the research plan is related to a thesis, only the study protocol, clinical study report, and study results will be published. The participant data file contains information about the participants, and due to the preservation of individuals' privacy, it cannot be published."</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahsa Khajooei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.30, Hakim Azam St., Shiraz North St., Mollasadrah St.,  Khatam University Psychological and Counseling Clinic</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1991633357</zip>
        <telephone>+98 21 8917 0000</telephone>
        <email>m.khajavi@khatam.ac.ir</email>
        <affiliation>Khatam University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Marzie Hashemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No.30, Hakim Azam St., Shiraz North St., Mollasadrah St.,  Khatam University</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1991633357</zip>
        <telephone>+98 21 8917 0000</telephone>
        <email>hashemi.hs@gmail.com</email>
        <affiliation>Khatam University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Clients to the Imam Hossein psychiatric clinic in Tehran
Diagnosed with generalized anxiety disorder (based on a psychiatric specialist's diagnosis)
At least 4 weeks should have passed since the medications were stabilized
Age range of 20 to 45 years
Middle socio-economic level
Intermediate level of education (from diploma to bachelor's degree)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Diagnosed Social anxiety disorder (based on a psychiatric specialist's diagnosis)
Patients with delusions and hallucinations (psychosis)
Patients with verbal disabilities (due to the impossibility of obtaining information from them)
Patients with generalized anxiety disorder who are currently going to psychotherapy sessions.
Patients with thyroid problems
Patients using drugs
Diagnosed with a mental disorder comorbid</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F41.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Generalized anxiety disorder</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>"Intervention group: 5 participants in the research study, diagnosed with generalized anxiety disorder, participate in 10 individual psychotherapy sessions.The duration of each session is one hour. During the sessions Using the integrated protocol of Leahy's emotional schema therapy and Barlow's integrative transdiagnostic therapy , the evaluation and modification of emotional schemas, cognitive reconstruction, training and application of mindfulness, emotional regulation, and cognitive flexibility are addressed. Description of the intervention : Pre- Assessment The first stage involves a comprehensive assessment to evaluate the patient's level of anxiety, emotional regulation abilities, and executive function performance. Standardized assessment tools like the Generalized Anxiety Disorder 7-item (GAD-7) scale, Cognitive Regulation of Emotion Questionnaire (Garnefski and Kraaij, 2006), and Persian version of Adult Executive Functions Scale (Parhun et al., 2023) will be used. Schema Identification : We begin by identifying the patient's schemas that relate to their anxiety, focusing on the cognitive, emotional, and behavioral responses that contribute to their Generalized anxiety disorder. Schema Modification : Through a process of cognitive restructuring, patients are guided to challenge their schemas, change their maladaptive thought patterns, and develop healthier ways of interpreting their experiences.Emotional Regulation Training : We utilize the techniques from Dialectical Behavior Therapy (DBT) and Acceptance and Commitment Therapy (ACT) to teach patients skills to understand and manage their emotions better. Cognitive Flexibility Training : Using a combination of cognitive-behavioral techniques and mindfulness practices, we aim to enhance the patient's ability to shift their attention and adapt their thinking in response to changing circumstances.  Schema- Focused Emotional Regulation : After separately working on Emotional Schema Therapy and Integrated Transdiagnostic Therapy  , we integrate the two by focusing on schema-focused emotional regulation. This helps patients recognize and alter schemas while simultaneously regulating their emotions. Cognitive Flexibility and Schema Modification:  As patients gain better control over their emotional responses, we further integrate cognitive flexibility training within schema modification, which aids them to challenge and change their schemas more effectively.Post- Assessment : The same standardized tools used in the pre-assessment will be employed to evaluate the progress and efficacy of the therapy. Finally, patients are provided with strategies and plans to maintain their gains and cope with potential future stressors. Regular follow-ups are conducted to reinforce the therapy's effectiveness and manage any recurring symptoms</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The score of Executive Functions the short Persian form (Parhun et al., 2023) of the Adult Self-Report of Executive Functions Scale (Roth et al.) is obtained. Timepoint: "Before the start of the study, three times at intervals of one week, then at 3, 6, 9 weeks after the start of psychotherapy sessions, once at the end of the treatment, and once 1 month after the end of therapy sessions.". Method of measurement: Persian version of Adult Executive Functions Scale (normized version of Behavioral Rating of Executive Functions) Roth et al.</prim_outcome>
      <prim_outcome>The score of the Cognitive Emotion Regulation Questionnaire (Garnefski and Kraaij, 2006). Timepoint: "Before the start of the study, three times at intervals of one week, then at 3, 6, 9 weeks after the start of psychotherapy sessions, once at the end of the treatment, and once 1 month after the end of therapy sessions.". Method of measurement: Cognitive Regulation of Emotion Questionnaire (Garnefski and Kraaij, 2006).</prim_outcome>
      <prim_outcome>The score of the Generalized Anxiety Disorder questionnaire (GAD-7). Timepoint: "Before the start of the study, three times at intervals of one week, then at 3, 6, 9 weeks after the start of psychotherapy sessions, once at the end of the treatment, and once 1 month after the end of therapy sessions.". Method of measurement: Generalized Anxiety Disorder Scale Questionnaire (GAD-7).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khatam University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-29</approval_date>
        <contact_name>Ethics Committee of Shahid Beheshti University</contact_name>
        <contact_address>Shahid Shahriari square., Evin., Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
